Diabetes Therapy
Effects of tight glycemic and blood pressure control investigated
Published in Obesity and Diabetes Week, October 3rd, 2005
According to a study from Australia and England, "The burden of type 2 diabetes is growing rapidly worldwide, across high-, middle-, and low-income countries. This burden is associated primarily with increased risks of macrovascular and microvascular diseases, and it is agreed that multifactorial treatment regimens are required to reduce it. ADVANCE (Action in Diabetes and Vascular disease: Preterax and Diamicron-MR Controlled Evaluation) is a large-scale, 2 x 2 factorial, randomized clinical trial."
"It will...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Epidemiology
Incidence of type 2 diabetes increasing in children in Tokyo - Diabetes Therapy
(Pro3)GIP improves glucose tolerance and reduces insulin resistance - Diabetes Therapy
Beta3 -adrenoceptor agonist increases plasma adiponectin levels - Obesity Pathogenesis
Suppressed skeletal muscle thermogenesis plays role in weight change - Obesity Risk Factors
Variants of ENPP1 are associated with childhood and adult obesity - Age-Related Macular Degeneration
Patent issued in relation to squalamine and other aminosterols - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
